|
Atypical Neuroleptics
Citations 41-47 of 47 total displayed.
|
Past content
(since Jun 2002):
|
- LETTERS TO THE EDITOR
Olanzapine and Neuroleptic Malignant Syndrome
- Ian Tofler
Psychosomatics 2002; 43: 505-506.
[Full text]
[PDF]
- LETTERS TO THE EDITOR
Drs. Philibert and Carney-Doebbeling Reply
- Robert Philibert and Caroline Carney-Doebbeling
Psychosomatics 2002; 43: 506.
[Full text]
[PDF]
- REVIEW ARTICLES
Cataract Occurrence With Antipsychotic Drugs
- Sajida Shahzad, Mohammad-Irfan Suleman, Hasan Shahab, Iourii Mazour, Amanpreet Kaur, Peter Rudzinskiy, and Steven Lippmann
Psychosomatics 2002; 43: 354-359.
[Abstract]
[Full text]
[PDF]
- CASE REPORTS
Polyserositis, Acute Withdrawal, and Relapse After Abrupt Clozapine Discontinuation
- Shishuka Malhotra, Kathleen Franco, J. Walton Tomford, and Rukhsana Iqbal
Psychosomatics 2002; 43: 418-420.
[Full text]
[PDF]
- CASE REPORTS
Olanzapine-Induced EDTA-Dependent Pseudothrombocytopenia
- Chun-Hsien Tu and Stone Yang
Psychosomatics 2002; 43: 421-423.
[Full text]
[PDF]
- REVIEW ARTICLES
The Role of Atypical Antipsychotics in the Treatment of Delirium
- Thomas L. Schwartz and Prakash S. Masand
Psychosomatics 2002; 43: 171-174.
[Abstract]
[Full text]
[PDF]
- ORIGINAL RESEARCH REPORTS
An Open Trial of Olanzapine for the Treatment of Delirium in Hospitalized Cancer Patients
- William Breitbart, Annie Tremblay, and Christopher Gibson
Psychosomatics 2002; 43: 175-182.
[Abstract]
[Full text]
[PDF]
|
|
